The FDA approved Evrysdi in 2020 and has treated over 21,000 patients worldwide. In 2024, Evrysdi generated sales of ...

“Instead of making my payments, I was thinking I can go to the casino and double it to make payments and things like that,” ...

Shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose sharply during Wednesday's session after the company announced it ...

XRP (CRYPTO: XRP) has crashed 48% from its $3.65 July peak despite winning the SEC lawsuit, landing $1 billion in ETF inflows ...

PowerBank entered a revolving credit facility of up to $8 million with NY Green Bank, a division of the New York State Energy ...

Making a noteworthy insider sell on December 30, John Swallow, President & CEO at Idaho Strategic Resources (AMEX: IDR ), is ...

Corcept Therapeutics stock falls after FDA rejects relacorilant for hypertension secondary to hypercortisolism; company to ...

Asset management firm Cantor describes 2025 as a pivotal year for crypto regulation, institutional adoption and innovation, ...

Small and mid-cap biotech stocks entered 2025 like a compressed spring, and it finally snapped higher— here's why.

CEO and Nike board member Tim Cook disclosed in a regulatory filing last week that he purchased 50,000 shares of Nike at an ...

“2025 was supposed to be the year of the AI agent,” reporter Joanna Stern said in a YouTube video documenting the experiment.

Chinese automakers record EV market share in Europe with BYD, Stellantis-backed Leapmotor and Chery leading the charge.